New Market Research Report: Aegera Therapeutics Inc. - Product Pipeline Review - 2013

From: Fast Market Research, Inc.
Published: Tue Jul 30 2013


Global Market Direct's pharmaceuticals report, "Aegera Therapeutics Inc. - Product Pipeline Review - 2013" provides data on the Aegera Therapeutics Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Aegera Therapeutics Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Aegera Therapeutics Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Aegera Therapeutics Inc. - Brief Aegera Therapeutics Inc. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Aegera Therapeutics Inc. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Aegera Therapeutics Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Aegera Therapeutics Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- http://www.fastmr.com/prod/647144_aegera_therapeutics_inc_product_pipeline_review.aspx?afid=303

Reasons to Get this Report

* Evaluate Aegera Therapeutics Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Aegera Therapeutics Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Aegera Therapeutics Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Aegera Therapeutics Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Aegera Therapeutics Inc. and identify potential opportunities in those areas.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Aegera Therapeutics Inc. - Product Pipeline Review - 2012
- Nektar Therapeutics - Product Pipeline Review - 2013
- Addex Therapeutics - Product Pipeline Review - 2013
- United Therapeutics Corporation - Product Pipeline Review - 2013
- Sarepta Therapeutics, Inc. - Product Pipeline Review - 2013

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »